Two Sigma Investments
AARD

Two Sigma Investments’s Aardvark Therapeutics AARD Stock Holding History

Two Sigma Investments’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$616K Buy
163,355
+34,569
+27% +$358K ﹤0.01% 3589
2025
Q4 		$1.69M Buy
128,786
+65,217
+103% +$814K ﹤0.01% 2557
2025
Q3 		$845K Buy
+63,569
New +$717K ﹤0.01% 2689
2025
Q2 		– Sell
-15,424
Closed -$116K – 3648
2025
Q1 		$116K Buy
+15,424
New +$173K ﹤0.01% 2948

Other funds holding AARD

DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments's AARD Position: Q1 2026 in Review

Two Sigma Investments increased its Aardvark Therapeutics (AARD) stake by 27% in Q1 2026, buying an estimated $358K and bringing the position to 163,355 shares worth $616K. The position accounts for ﹤0.01% of the portfolio, ranked #3589.

Two Sigma Investments first reported a position in AARD in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.69M in Q4 2025. 79 funds tracked by Wall St. Rank hold AARD as of Q1 2026.

  • Two Sigma Investments held 163,355 shares of Aardvark Therapeutics worth $616K as of Q1 2026.
  • Two Sigma Investments bought 34,569 Aardvark Therapeutics shares in Q1 2026, an estimated $358K.
  • Aardvark Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3589 holding.
  • Two Sigma Investments first reported a position in Aardvark Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Two Sigma Investments's Aardvark Therapeutics position peaked at $1.69M in Q4 2025.
  • 79 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.